AR and adenocarcinoma: This trans-differentiation model suggests that adenocarcinoma cells undergo lineage switching to the neuroendocrine lineage via genetic and epigenetic dysregulation relinquishing their dependence on the AR pathway and activating alternative mitogenic pathways, epithelial–mesenchymal transition, and stem cell programs [10,11,18].